Accentia Biopharmaceuticals, Inc. (ABPI) Income Statement

Products	711.24K
Services	191.91K
Grant revenue	0
Total net sales	903.16K
Products	475.97K
Services	252.41K
Grants	0
Total cost of sales (exclusive of amortization of acquired product rights)	728.39K
Gross margin	174.77K
Research and development	1.13M
Sales and marketing	36.52K
Royalties	0
General and administrative	1.18M
Impairment of intangible assets
Total operating expenses	2.35M
Operating loss	-2.17M
Interest expense
Derivative gain (loss)	1.34M
Loss on deconsolidation of insolvent subsidiary
Other income (expense)	-4.15K
Income (loss) before reorganization items, non-controlling interest in losses from variable interest entities, and income taxes	-2.73M
Gain on reorganization	5.08M
Professional Fees	-8.93K
Provision for indemnity agreements
Total reorganization items	5.07M
Loss before income taxes and non-controlling interest	2.34M
Income taxes	0
Net (loss) income
Loss (income) from non-controlling interest from variable interest entities and subsidiary	791.98K
Net (loss) income attributable to Accentia Biopharmaceuticals, Inc.
Preferred stock dividend
(Loss) income attributable to common shareholders	3.13M
Weighted average shares outstanding, basic and diluted
(Loss) income attributable to common stockholders per common share

Entities mentioned with ABPI

View All Entities